Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICAND phase II deferiprone trial in PKAN
2008-003059-56Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of deferiprone in pantothenate kinase-associated neurodegeneration (PKAN), sponsored by Carlo Besta Neurological Institute. Primary endpoint: Change in MRI-determined iron concentration in both globus pallidus. Started Jul 2008; status: completed.
02
Drugs
deferiprone
03
Conditions
pantothenate kinase-associated neurodegeneration (PKAN)
Beyond the preview
Go deeper on 2008-003059-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003059-56.